信隆健康
(002105)
| 流通市值：22.05亿 | | | 总市值：22.16亿 |
| 流通股本：3.64亿 | | | 总股本：3.66亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 717,097,027.34 | 359,564,905.91 | 1,187,687,703.11 | 863,891,372.59 |
| 营业收入 | 717,097,027.34 | 359,564,905.91 | 1,187,687,703.11 | 863,891,372.59 |
| 二、营业总成本 | 725,270,304.61 | 360,133,901.34 | 1,218,348,833.32 | 889,975,473.19 |
| 营业成本 | 624,048,372.3 | 312,321,001.81 | 1,038,827,229.55 | 759,142,154.41 |
| 税金及附加 | 5,470,554.03 | 2,924,591.12 | 9,251,550.43 | 6,980,944.57 |
| 销售费用 | 19,620,973.98 | 8,836,748.79 | 40,170,864.59 | 31,353,392.35 |
| 管理费用 | 38,932,346.92 | 17,992,649.68 | 78,444,602.09 | 57,699,059.52 |
| 研发费用 | 20,657,874.76 | 9,848,134.28 | 41,896,323.01 | 30,474,631.63 |
| 财务费用 | 16,540,182.62 | 8,210,775.66 | 9,758,263.65 | 4,325,290.71 |
| 其中:利息费用 | 8,040,738.14 | 3,979,753.78 | 20,675,894.97 | 11,866,706.06 |
| 其中:利息收入 | 2,368,122.24 | 1,183,304.99 | 9,914,572.87 | 5,212,690.73 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | -3,631,921.46 | -948,063.19 | -3,973,855.94 | -2,459,481.16 |
| 资产处置收益 | -474,814.71 | -44,395.4 | 34,776.61 | -31,886.65 |
| 资产减值损失(新) | -2,102,022.57 | - | -33,850,909.56 | -3,234,411.38 |
| 信用减值损失(新) | 777,432.29 | - | -6,612,766.05 | 494,741.69 |
| 其他收益 | 849,190.09 | 437,414.81 | 1,955,433.43 | 1,755,656.52 |
| 四、营业利润 | -12,755,413.63 | -1,124,039.21 | -73,108,451.72 | -29,559,481.58 |
| 加:营业外收入 | 22,806,071.17 | 68,737.13 | 9,622,978.87 | 5,961,181.03 |
| 减:营业外支出 | 1,134,835.56 | 502,497.54 | 3,737,480.49 | 2,917,598.26 |
| 五、利润总额 | 8,915,821.98 | -1,557,799.62 | -67,222,953.34 | -26,515,898.81 |
| 减:所得税费用 | 2,179,848.61 | 396,037.17 | 670,568.33 | 5,864,052.7 |
| 六、净利润 | 6,735,973.37 | -1,953,836.79 | -67,893,521.67 | -32,379,951.51 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 6,735,973.37 | -1,953,836.79 | -67,893,521.67 | -32,379,951.51 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 8,034,466.84 | -1,943,906.19 | -64,114,657.08 | -30,138,799.75 |
| 少数股东损益 | -1,298,493.47 | -9,930.6 | -3,778,864.59 | -2,241,151.76 |
| 扣除非经常损益后的净利润 | -13,654,694.18 | -1,885,492.19 | -71,780,175.57 | -34,019,142.75 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.02 | -0.01 | -0.17 | -0.08 |
| (二)稀释每股收益 | 0.02 | -0.01 | -0.17 | -0.08 |
| 八、其他综合收益 | -6,583,998.71 | -5,803,445.63 | -6,399,028.37 | -5,817,296.74 |
| 归属于母公司股东的其他综合收益 | -4,411,689.77 | -3,916,719.37 | -4,289,139.22 | -3,924,523.71 |
| 九、综合收益总额 | 151,974.66 | -7,757,282.42 | -74,292,550.04 | -38,197,248.25 |
| 归属于母公司股东的综合收益总额 | 3,622,777.07 | -5,860,625.56 | -68,403,796.3 | -34,063,323.46 |
| 归属于少数股东的综合收益总额 | -3,470,802.41 | -1,896,656.86 | -5,888,753.74 | -4,133,924.79 |
| 公告日期 | 2026-08-22 | 2026-04-29 | 2026-04-24 | 2025-10-25 |
| 审计意见(境内) | | | 标准无保留意见 | |